Psychiatry Flashcards
Tricyclic Antidepressants
Name (3) and MoA
Amitriptyline, Lofepramie, Imipramine
Inhibit neuronal reuptake of NA and 5HT-3 at synaptic cleft to increase neuroavailability
TCAs - Indications
Moderate-severe depression treatment, neuropathic pain (unlicensed)
TCAs - Contraindicaitons
Elderly, CVD (prolongs QT), epilepsy, constipation, BPH, raised intraocular pressure
TCAs - Side effects
Mainly caused by reuptake inhibition of muscarinic, histamine, alpha-adrenergic and dopamine receptors.
Toxicity at high dose –> cardiac arrest.
High risk of suicidal thoughts
Dry mouth, constipation, retention, blurred vision, sedation, hypotension, QT^, sexual dysfunction, extrapyramidal sx (tremor, dyskinesia)
TCA - interactions
MAOIs - synergistic
SSRIs - name (4) and mechanism
Citalopram, sertraline, fluoxetine, esciptalopram
MoA - preferential inhibition of 5-HT reuptake, improves mood and relieves panic/obsession
SSRI Indications
First line moderate-severe depression medicaiton, panic disorder, OCD
SSRI contraindicaitons
Epilepsy, PUD, young, hepatic imp
Paroxetine - C/I in pregnancy
SSRI side effects
GI - appetite/weight, nausea, vomiting, diarrhoea (squirtraline) hyponatraemia, suicidal thoughts (in young), serotonin syndrome, QT^
Neuro - insomnia, irritability, sometimes mania, anxiety
Spinal - ED
Discontinuation - other than fluoxetine, rapid withdrawal can cause anxiety, headaches, sweats
SSRI interactions
MAOI/SNRIs - risk of serotonin syndrome Fluoxetine - long T1/2 Paroxetine - short onset/offset Aspirin/NSAIDs - caution with PUD Other QT^ drugs (esp Citalopram)
Benzodiazepines Name (5) and mechanism
Diazepam (2-keto, long half-life) Lorazepam (3-hydroxy, short half-life) Chlordiazepoxide Midazolam Nitrazepam
GABA(A) agonist increase Cl- inflow to decrease stimulation reducing anxiety, leads to sleepiness sedation, anti-convulsive
Benzos - Indications (5)
Seizures Alcohol WD Sedation Short-term (severe) anxiety relief (e.g. pre-operative) Insomnia
Benzos - Contraindications/Cautions
Stronger in elderly (risk of falls) Respiratory Depression NMD Liver failure (due to metabolism) In drink - more potent
Benzos - Side Effects
Sedation/coma - risk of falls
Some central respiratory depression in OD
Anterograde amnesia/confusion
Loss of AW reflexes
Dependence/tolerance/withdrawal (minimise duration)
Benzos - Interactions (2)
Additive to other sedatives
Dep on CYP450 for clearance
Acetylcholinesterase inhibitors
Name (3) and Mechanism
Donepazil, galantamine, rivastigmine
Irreversibly binds cholinesterase to inhibit ACh hydrolysis and increase availability at synapse, thereby stimulating neurones
AChEi
Indications
Mild-severe dementia assoc with Alzheimer’s
AChEi
Side Effects
Muscle cramping, joint pain, ^micturition/incontinence, seizures, faints, arrhythmias, GI ulceration
AChEi
Interactions
Atropine - counters
CYP450 as elimination hepatic
Z-drugs
Name (2) and Mechanism
Zopidem/Zopiclone
Act on GABA(A) receptor subunit alpha-1 to increase Cl- influx into neurone and reduce stimulation (hyperpolarisation)
Z-drugs
Indication
Insomnia
Z-drugs
Cautions/Contraindications
Contra-indicated in myaesthenia gravis, hepatic impairment
Caution dependence, withdrawal
Z-drugs
Side Effects
Dry mouth
CNS depression - drowsiness, dysguesia (bitter)
Name a drug used for Generalised Anxiety Disorder AND/OR Neuropathic pain (/Epilepsy)
Pregabalin
Pregabalin
Cautions/Contraindications
Renal clearance - caution in renal impairment
Increases appetite - caution in diabetes
Pregabalin
Side Effects
Increased appetite/weight gain Nasopharyngitis Euphoria/confusion Dizziness/drowsiness Diplopia GI upset
Mechanism of Action of Memantine
Memantine is an NMDA antagonist - this prevents the excitotoxic glutamate from opening the NMDA channel to inhibit Na influx to cells, reducing toxic excitation
Monoamine Oxidase Inhibitors (MAOIs)
Name (2)
Mechanism
Hydrazine / Selegiline
Inhibit pre-synaptic monoamine oxidase enzyme to increase neurotransmitter availability